Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1996 Mar;164(3):238–248.

Applying the results of large clinical trials in the management of acute myocardial infarction.

J P Sweeney 1, G G Schwartz 1
PMCID: PMC1303418  PMID: 8775936

Abstract

Mortality from acute myocardial infarction has declined in recent years, largely due to the widespread application of new pharmacologic and mechanical interventions that have been tested in large, prospective, randomized clinical trials. For practicing generalists, we review the key data from such trials that have shaped the current management of patients with acute myocardial infarction. We discuss the roles of thrombolytic therapy, coronary angioplasty, nitrates, beta- and calcium channel blockers, angiotensin-converting-enzyme inhibitors, magnesium, and antiarrhythmic and antithrombotic agents. In addition, we highlight critical unanswered questions in the management of this disorder.

Full text

PDF
238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med. 1995 Jan 12;332(2):80–85. doi: 10.1056/NEJM199501123320203. [DOI] [PubMed] [Google Scholar]
  2. Asinger R. W., Mikell F. L., Elsperger J., Hodges M. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med. 1981 Aug 6;305(6):297–302. doi: 10.1056/NEJM198108063050601. [DOI] [PubMed] [Google Scholar]
  3. Burkart F., Pfisterer M., Kiowski W., Follath F., Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) J Am Coll Cardiol. 1990 Dec;16(7):1711–1718. doi: 10.1016/0735-1097(90)90324-i. [DOI] [PubMed] [Google Scholar]
  4. Ceremuzynski L., Kleczar E., Krzeminska-Pakula M., Kuch J., Nartowicz E., Smielak-Korombel J., Dyduszynski A., Maciejewicz J., Zaleska T., Lazarczyk-Kedzia E. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol. 1992 Nov 1;20(5):1056–1062. doi: 10.1016/0735-1097(92)90357-s. [DOI] [PubMed] [Google Scholar]
  5. Chadda K., Goldstein S., Byington R., Curb J. D. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 1986 Mar;73(3):503–510. doi: 10.1161/01.cir.73.3.503. [DOI] [PubMed] [Google Scholar]
  6. DeWood M. A., Notske R. N., Berg R., Jr, Ganji J. H., Simpson C. S., Hinnen M. L., Selinger S. L., Fisher L. D. Medical and surgical management of early Q wave myocardial infarction. I. Effects of surgical reperfusion on survival, recurrent myocardial infarction, sudden death and functional class at 10 or more years of follow-up. J Am Coll Cardiol. 1989 Jul;14(1):65–77. doi: 10.1016/0735-1097(89)90055-7. [DOI] [PubMed] [Google Scholar]
  7. DeWood M. A., Spores J., Notske R., Mouser L. T., Burroughs R., Golden M. S., Lang H. T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980 Oct 16;303(16):897–902. doi: 10.1056/NEJM198010163031601. [DOI] [PubMed] [Google Scholar]
  8. Ellis S. G., da Silva E. R., Heyndrickx G., Talley J. D., Cernigliaro C., Steg G., Spaulding C., Nobuyoshi M., Erbel R., Vassanelli C. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 1994 Nov;90(5):2280–2284. doi: 10.1161/01.cir.90.5.2280. [DOI] [PubMed] [Google Scholar]
  9. Furberg C. D., Hawkins C. M., Lichstein E. Effect of propranolol in postinfarction patients with mechanical or electrical complications. Circulation. 1984 Apr;69(4):761–765. doi: 10.1161/01.cir.69.4.761. [DOI] [PubMed] [Google Scholar]
  10. Fuster V., Dyken M. L., Vokonas P. S., Hennekens C. Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group. Circulation. 1993 Feb;87(2):659–675. doi: 10.1161/01.cir.87.2.659. [DOI] [PubMed] [Google Scholar]
  11. Gibbons R. J., Holmes D. R., Reeder G. S., Bailey K. R., Hopfenspirger M. R., Gersh B. J. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med. 1993 Mar 11;328(10):685–691. doi: 10.1056/NEJM199303113281003. [DOI] [PubMed] [Google Scholar]
  12. Gibson R. S., Boden W. E., Theroux P., Strauss H. D., Pratt C. M., Gheorghiade M., Capone R. J., Crawford M. H., Schlant R. C., Kleiger R. E. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med. 1986 Aug 14;315(7):423–429. doi: 10.1056/NEJM198608143150704. [DOI] [PubMed] [Google Scholar]
  13. Gomez-Marin O., Folsom A. R., Kottke T. E., Wu S. C., Jacobs D. R., Jr, Gillum R. F., Edlavitch S. A., Blackburn H. Improvement in long-term survival among patients hospitalized with acute myocardial infarction, 1970 to 1980. The Minnesota Heart Survey. N Engl J Med. 1987 May 28;316(22):1353–1359. doi: 10.1056/NEJM198705283162201. [DOI] [PubMed] [Google Scholar]
  14. Grines C. L., Browne K. F., Marco J., Rothbaum D., Stone G. W., O'Keefe J., Overlie P., Donohue B., Chelliah N., Timmis G. C. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993 Mar 11;328(10):673–679. doi: 10.1056/NEJM199303113281001. [DOI] [PubMed] [Google Scholar]
  15. Hine L. K., Laird N., Hewitt P., Chalmers T. C. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med. 1989 Dec;149(12):2694–2698. [PubMed] [Google Scholar]
  16. Jugdutt B. I., Warnica J. W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. Circulation. 1988 Oct;78(4):906–919. doi: 10.1161/01.cir.78.4.906. [DOI] [PubMed] [Google Scholar]
  17. Kim C. B., Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation. 1993 Nov;88(5 Pt 1):2426–2436. doi: 10.1161/01.cir.88.5.2426. [DOI] [PubMed] [Google Scholar]
  18. Lancet D. Olfaction. Exclusive receptors. Nature. 1994 Nov 24;372(6504):321–322. doi: 10.1038/372321a0. [DOI] [PubMed] [Google Scholar]
  19. Mark D. B., Hlatky M. A., Califf R. M., Naylor C. D., Lee K. L., Armstrong P. W., Barbash G., White H., Simoons M. L., Nelson C. L. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med. 1995 May 25;332(21):1418–1424. doi: 10.1056/NEJM199505253322106. [DOI] [PubMed] [Google Scholar]
  20. Muller D. W., Topol E. J. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med. 1990 Dec 15;113(12):949–960. doi: 10.7326/0003-4819-113-12-949. [DOI] [PubMed] [Google Scholar]
  21. Naylor C. D., Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol. 1994 Nov 15;24(6):1431–1438. doi: 10.1016/0735-1097(94)90136-8. [DOI] [PubMed] [Google Scholar]
  22. O'Neill W. W. Angioplasty therapy of cardiogenic shock: are randomized trials necessary? J Am Coll Cardiol. 1992 Apr;19(5):915–917. doi: 10.1016/0735-1097(92)90270-w. [DOI] [PubMed] [Google Scholar]
  23. Olsson G., Odén A., Johansson L., Sjögren A., Rehnqvist N. Prognosis after withdrawal of chronic postinfarction metoprolol treatment: a 2-7 year follow-up. Eur Heart J. 1988 Apr;9(4):365–372. doi: 10.1093/oxfordjournals.eurheartj.a062512. [DOI] [PubMed] [Google Scholar]
  24. Pedersen T. R. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med. 1985 Oct 24;313(17):1055–1058. doi: 10.1056/NEJM198510243131705. [DOI] [PubMed] [Google Scholar]
  25. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  26. Reeder G. S., Gersh B. J. Modern management of acute myocardial infarction. Curr Probl Cardiol. 1993 Feb;18(2):81–155. doi: 10.1016/0146-2806(93)90018-w. [DOI] [PubMed] [Google Scholar]
  27. Simari R. D., Berger P. B., Bell M. R., Gibbons R. J., Holmes D. R., Jr Coronary angioplasty in acute myocardial infarction: primary, immediate adjunctive, rescue, or deferred adjunctive approach? Mayo Clin Proc. 1994 Apr;69(4):346–358. doi: 10.1016/s0025-6196(12)62220-4. [DOI] [PubMed] [Google Scholar]
  28. Simoons M. L., Maggioni A. P., Knatterud G., Leimberger J. D., de Jaegere P., van Domburg R., Boersma E., Franzosi M. G., Califf R., Schröder R. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet. 1993 Dec 18;342(8886-8887):1523–1528. doi: 10.1016/s0140-6736(05)80089-3. [DOI] [PubMed] [Google Scholar]
  29. Sintek C. F., Pfeffer T. A., Khonsari S. Surgical revascularization after acute myocardial infarction. Does timing make a difference? J Thorac Cardiovasc Surg. 1994 May;107(5):1317–1322. [PubMed] [Google Scholar]
  30. Smith P., Arnesen H., Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med. 1990 Jul 19;323(3):147–152. doi: 10.1056/NEJM199007193230302. [DOI] [PubMed] [Google Scholar]
  31. Teo K. K., Yusuf S., Collins R., Held P. H., Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ. 1991 Dec 14;303(6816):1499–1503. doi: 10.1136/bmj.303.6816.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Vaitkus P. T., Barnathan E. S. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol. 1993 Oct;22(4):1004–1009. doi: 10.1016/0735-1097(93)90409-t. [DOI] [PubMed] [Google Scholar]
  33. Woods K. L., Fletcher S., Roffe C., Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet. 1992 Jun 27;339(8809):1553–1558. doi: 10.1016/0140-6736(92)91828-v. [DOI] [PubMed] [Google Scholar]
  34. Wyse D. G., Kellen J., Rademaker A. W. Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction. J Am Coll Cardiol. 1988 Aug;12(2):507–513. doi: 10.1016/0735-1097(88)90427-5. [DOI] [PubMed] [Google Scholar]
  35. Yusuf S., Collins R., MacMahon S., Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988 May 14;1(8594):1088–1092. doi: 10.1016/s0140-6736(88)91906-x. [DOI] [PubMed] [Google Scholar]
  36. Zijlstra F., de Boer M. J., Hoorntje J. C., Reiffers S., Reiber J. H., Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993 Mar 11;328(10):680–684. doi: 10.1056/NEJM199303113281002. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES